[Federal Register Volume 88, Number 73 (Monday, April 17, 2023)]
[Notices]
[Page 23428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07991]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-PS23-001, Increasing PrEP Use Among Black 
Cisgender Women in the United States (HerPrEP) and RFA-PS23-005, 
Expanding Rapid Initiation of Antiretroviral Therapy in Non-Traditional 
Settings: Emergency Department; Amended Notice of Closed Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-PS-23-001, Increasing PrEP Use Among Black Cisgender Women 
in the United States (HerPrEP), and RFA-PS-23-005, Expanding Rapid 
Initiation of Antiretroviral Therapy in Non-traditional Settings: 
Emergency Department; May 24-25, 2023, 10 a.m.-5 p.m. EDT, 
Teleconference, Centers for Disease Control and Prevention, Room 1077, 
8 Corporate Blvd., Atlanta, GA 30329 in the original Federal Register 
Notice. The meeting was published in the Federal Register on March 8, 
2023, Volume 88, Number 45, pages 14372-14373.
    The meeting is being amended to remove the second day of the 
meeting. The notice should read as follows:
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-PS-23-001, Increasing PrEP 
Use Among Black Cisgender Women in the United States (HerPrEP), and 
RFA-PS-23-005, Expanding Rapid Initiation of Antiretroviral Therapy in 
Non-traditional Settings: Emergency Department.
    Date: May 24, 2023.
    Time: 10 a.m.-5 p.m., EDT.
    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, Centers for Disease Control and Prevention, 
1600 Clifton Road NE, Mailstop US8-1, Atlanta, Georgia 30329-4027. 
Telephone: (404) 718-8833; Email: [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-07991 Filed 4-14-23; 8:45 am]
BILLING CODE 4163-18-P